Kidney disease is often called a “silent disease” because kidney damage happens quietly, without obvious symptoms in the ...

Abstract: Data-based machine learning methods have been successfully applied to control system design in recent years. However, safety during the learning and control process is difficult to guarantee ...

Bayer has started a phase 2a trial of an antibody that it hopes could provide a targeted, potentially disease-modifying therapy for Alport syndrome, a rare, genetic disease that leads to chronic ...

Bayer announced today initiation of a Phase IIa clinical trial with BAY 3401016, an investigational monoclonal antibody with potential to block a protein called Semaphorin 3A (Sema3A), which is ...

Allied Market Research published a report, titled, "Dyspnea treatment Market - Global Opportunity Analysis and Industry ...

A University of Cambridge study has identified 168 everyday chemicals that are toxic to beneficial gut bacteria and can ...

TIBSOVO is a targeted therapy that works against an abnormal protein created by a mutation in the IDH1 gene. This abnormal ...

肝硬化患者的感染现状肝硬化是各种慢性肝病进展至以肝脏弥漫性纤维化、假小叶形成、肝内外血管增殖为特征的病理阶段，伴随肝脏微循环障碍、免疫紊乱、肝脏局部至全身的炎症反应[1]。肝硬化患者可能发生感染等并发症[1]，自发性细菌性腹膜炎（SBP）是肝硬化患者 ...

Approximately 80% of cardiovascular disease is preventable through lifestyle modifications and risk factor management, according to the American Heart Association’s “Life's Essential Eight” framework, ...

Tanie, T. (2025) Loxoprofen-Induced Edema in an Elderly Male: A Case Report. Open Journal of Clinical Diagnostics, 15, ...

Kyoto, Japan -- The hepatitis C virus -- HCV -- can persist in the livers of those infected and even lead to liver disease or ...